Review: Some commercial or proprietary weight-loss programs increase weight loss
Authors: Scott Kahan, Kelly Theim
Journal: Annals of Internal Medicine (2015)

ACP Journal Club18 August 2015Review: Some commercial or proprietary weight-loss programs increase weight lossScott Kahan, MD, MPH, Kelly Theim, PhDScott Kahan, MD, MPHGeorge Washington University, National Center for Weight and Wellness, Washington, DC, USA (S.K.)Search for more papers by this author, Kelly Theim, PhDNational Center for Weight and Wellness, Washington, DC, USA (K.T.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJC-2015-163-4-008 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationGudzune KA, Doshi RS, Mehta AK, et al. Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med. 2015;162:501-12. https://pubmed.ncbi.nlm.nih.gov/25844997Clinical Impact RatingsGIM/FP/GP: References1. Knowler WC, Fowler SE, Hamman RF, et al; Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677-86. [PMID: 19878986] Google Scholar2. Foster GD, Wadden TA, Vogt RA, Brewer G. What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes. J Consult Clin Psychol. 1997;65:79-85. [PMID: 9103737] Google Scholar3. Jensen MD, Ryan DH, Apovian CM, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129:S102-38. [PMID: 24222017] Google Scholar4. Kolasa KM, Rickett K. Barriers to providing nutrition counseling cited by physicians: a survey of primary care practitioners. Nutr Clin Pract. 2010;25:502-9. [PMID: 20962310] Google Scholar5. Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27:155-61. [PMID: 14693982] Google Scholar Author, Article, and Disclosure InformationAuthors: Scott Kahan, MD, MPH; Kelly Theim, PhDAffiliations: George Washington University, National Center for Weight and Wellness, Washington, DC, USA (S.K.)National Center for Weight and Wellness, Washington, DC, USA (K.T.)This article was published at Annals.org on 4 August 2015. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 18 August 2015Volume 163, Issue 4Page: JC8KeywordsDatabasesDiabetes preventionDrug therapyHealth care providersMotivationOverweightPatientsSystematic reviewsWeight loss ePublished: 18 August 2015 Issue Published: 18 August 2015 Copyright & PermissionsCopyright © 2015 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...